Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal

BACKGROUND: HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and prophylactic lamivudine (LMV) treatment is suggested to prevent this phenomenon. However, the duration of LMV treatment in HSCT patients is not fully defined and the time of imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerva, C., Maffongelli, G., Svicher, V., Salpini, R., Colagrossi, L., Battisti, A., Mariotti, B., Cerretti, R., Cudillo, L., Sarmati, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557326/
https://www.ncbi.nlm.nih.gov/pubmed/28806922
http://dx.doi.org/10.1186/s12879-017-2672-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557326/
https://www.ncbi.nlm.nih.gov/pubmed/28806922
http://dx.doi.org/10.1186/s12879-017-2672-6

Ejemplares similares